Biogen Inc. (BIIB) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - General
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Biogen Inc.
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat…
Source: Yahoo Finance
Sector & Industry
Biogen Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry group. It is listed on the NASDAQ exchange.
Biogen Inc. at a Glance
| Company | Biogen Inc. |
| Ticker | BIIB |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $220.83 |
| Market cap | $32.63B |
| P/E ratio (trailing) | 39.22 |
| EPS (trailing) | $5.63 |
| 52-week high | $225.80 |
| 52-week low | $135.39 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.17 |
| Return on equity (ROE) | 4.58% |
| Debt-to-equity | 44.33% |
| Average volume | 1.12M |
| Shares outstanding | 147.75M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Employees | 7,500 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Biogen Inc.'s current P/E ratio?
- Biogen Inc. (BIIB) has a trailing P/E ratio of 39.22 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Biogen Inc.'s market capitalisation?
- Biogen Inc.'s market cap is $32.63B based on our latest snapshot. See how it ranks by market cap →
- What is BIIB's 52-week range?
- Over the past 52 weeks, BIIB has traded between $135.39 and $225.80. What does the 52-week range mean? →
- How volatile is Biogen Inc. compared to the market?
- Biogen Inc. has a beta of 0.17, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Biogen Inc. pay a dividend?
- Biogen Inc. does not currently pay a dividend according to our latest data.
- What exchange is BIIB listed on?
- BIIB is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Biogen Inc. in?
- Biogen Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →